Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials Early Breast Cancer Trialists' Collaborative Group The Lancet 366 (9503), 2087-2106, 2005 | 5042 | 2005 |
Triple-negative breast cancer: clinical features and patterns of recurrence R Dent, M Trudeau, KI Pritchard, WM Hanna, HK Kahn, CA Sawka, ... Clinical cancer research 13 (15), 4429-4434, 2007 | 4281 | 2007 |
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013 A Goldhirsch, EP Winer, AS Coates, RD Gelber, M Piccart-Gebhart, ... Annals of oncology 24 (9), 2206-2223, 2013 | 2862 | 2013 |
Everolimus in postmenopausal hormone-receptor–positive advanced breast cancer J Baselga, M Campone, M Piccart, HA Burris III, HS Rugo, T Sahmoud, ... New England Journal of Medicine 366 (6), 520-529, 2012 | 2713 | 2012 |
A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer RC Coombes, E Hall, LJ Gibson, R Paridaens, J Jassem, T Delozier, ... New England Journal of Medicine 350 (11), 1081-1092, 2004 | 2213 | 2004 |
A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer PE Goss, JN Ingle, S Martino, NJ Robert, HB Muss, MJ Piccart, ... New England Journal of Medicine 349 (19), 1793-1802, 2003 | 2201 | 2003 |
Polychemotherapy for early breast cancer: an overview of the randomised trials Early Breast Cancer Trialists' Collaborative Group The Lancet 352 (9132), 930-942, 1998 | 1862 | 1998 |
Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009 A Goldhirsch, JN Ingle, RD Gelber, AS Coates, B Thürlimann, HJ Senn Annals of oncology 20 (8), 1319-1329, 2009 | 1724 | 2009 |
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015 AS Coates, EP Winer, A Goldhirsch, RD Gelber, M Gnant, ... Annals of oncology 26 (8), 1533-1546, 2015 | 1548 | 2015 |
Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA. 17 PE Goss, JN Ingle, S Martino, NJ Robert, HB Muss, MJ Piccart, ... Journal of the National Cancer Institute 97 (17), 1262-1271, 2005 | 1317 | 2005 |
Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a … KS Albain, WE Barlow, S Shak, GN Hortobagyi, RB Livingston, IT Yeh, ... The lancet oncology 11 (1), 55-65, 2010 | 1291 | 2010 |
The effect of group psychosocial support on survival in metastatic breast cancer PJ Goodwin, M Leszcz, M Ennis, J Koopmans, L Vincent, H Guther, ... New England Journal of Medicine 345 (24), 1719-1726, 2001 | 1117 | 2001 |
Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women … P McGale, C Taylor, C Correa, D Cutter, F Duane, M Ewertz, R Gray, ... Lancet (London, England) 383 (9935), 2014 | 1108 | 2014 |
Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials. R Peto, C Davies, J Godwin, R Gray, HC Pan, M Clarke, D Cutter, S Darby, ... Lancet (London, England) 379 (9814), 432-444, 2011 | 1103 | 2011 |
American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor–positive … EP Winer, C Hudis, HJ Burstein, AC Wolff, KI Pritchard, JN Ingle, ... Journal of clinical oncology 23 (3), 619-629, 2005 | 1045 | 2005 |
Prospective validation of a 21-gene expression assay in breast cancer JA Sparano, RJ Gray, DF Makower, KI Pritchard, KS Albain, DF Hayes, ... New England Journal of Medicine 373 (21), 2005-2014, 2015 | 1040 | 2015 |
Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study PJ Goodwin, M Ennis, KI Pritchard, ME Trudeau, J Koo, Y Madarnas, ... Journal of clinical oncology 20 (1), 42-51, 2002 | 1011 | 2002 |
Effects of radiotherapy and surgery in early breast cancer—an overview of the randomized trials Early Breast Cancer Trialists' Collaborative Group New England Journal of Medicine 333 (22), 1444-1456, 1995 | 993 | 1995 |
Decreased levels of the cell-cycle inhibitor p27 Kip1 protein: prognostic implications in primary breast cancer C Catzavelos, N Bhattacharya, YC Ung, JA Wilson, L Roncari, C Sandhu, ... Nature medicine 3 (2), 227-230, 1997 | 989 | 1997 |
Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer JA Sparano, RJ Gray, DF Makower, KI Pritchard, KS Albain, DF Hayes, ... New England Journal of Medicine 379 (2), 111-121, 2018 | 900 | 2018 |